Flu season is in full swing and has already been linked to at least two deaths in Connecticut alone. Thus local health experts are cheering the approval of a new medication that can speed recovery from the contagious respiratory illness. Last week, the U.S. Food and Drug Administration approved the medication baloxavir marboxil, sold under the name Xofluza, for the treatment of influenza in patients 12 and older who have had symptoms for now more than 48 hours. It’s the first new antiviral flu treatment approved in roughly 20 years, only requires one dose and, according to research, can significantly shorten the length of illness. “This is great news,” said Dr. Zane Saul, chief of infectious disease at Bridgeport Hospital.
from News https://www.ctpost.com/local/article/As-flu-season-builds-in-state-FDA-approves-13352071.php
No comments:
Post a Comment